147 related articles for article (PubMed ID: 12841564)
21. 3D volume-ablation rate and thermal side effects with the Er:YAG and Nd:YAG laser.
Mehl A; Kremers L; Salzmann K; Hickel R
Dent Mater; 1997 Jul; 13(4):246-51. PubMed ID: 11696904
[TBL] [Abstract][Full Text] [Related]
22. Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview.
Katsanos A; Tsaldari N; Gorgoli K; Lalos F; Stefaniotou M; Asproudis I
Adv Ther; 2020 Apr; 37(4):1319-1327. PubMed ID: 32086749
[TBL] [Abstract][Full Text] [Related]
23. Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters.
Vandorselaer T; Van De Velde F; Tassignon MJ
Bull Soc Belge Ophtalmol; 2001; (280):15-9. PubMed ID: 11486460
[TBL] [Abstract][Full Text] [Related]
24. Root substance removal with Er:YAG laser radiation at different parameters using a new delivery system.
Folwaczny M; Mehl A; Haffner C; Benz C; Hickel R
J Periodontol; 2000 Feb; 71(2):147-55. PubMed ID: 10711604
[TBL] [Abstract][Full Text] [Related]
25. Erbium: YAG laser ablation of retinal tissue under perfluorodecaline: determination of laser-tissue interaction in pig eyes.
Wesendahl T; Janknecht P; Ott B; Frenz M
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):505-12. PubMed ID: 10670482
[TBL] [Abstract][Full Text] [Related]
26. Pulsed Erbium:YAG laser ablation in cutaneous surgery.
Kaufmann R; Hibst R
Lasers Surg Med; 1996; 19(3):324-30. PubMed ID: 8923427
[TBL] [Abstract][Full Text] [Related]
27. High-speed photography of Er: YAG laser ablation in fluid. Implication for laser vitreous surgery.
Lin CP; Stern D; Puliafito CA
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2546-50. PubMed ID: 2265992
[TBL] [Abstract][Full Text] [Related]
28. Comparison of erbium:yttrium-aluminum-garnet-laser vitrectomy and mechanical vitrectomy: a clinical study.
Petersen H; Mrochen M; Seiler T
Ophthalmology; 2000 Jul; 107(7):1389-92. PubMed ID: 10889118
[TBL] [Abstract][Full Text] [Related]
29. [Cavitation bubble formation during Erbium:YAG laser vitrectomy].
Mrochen M; Riedel P; Donitzky C; Seiler T
Ophthalmologe; 2001 Feb; 98(2):163-7. PubMed ID: 11263042
[TBL] [Abstract][Full Text] [Related]
30. Effect of energy and pulse repetition rate of Er: YAG laser on dentin ablation ability and morphological analysis of the laser-irradiated substrate.
Corona SA; de Souza AE; Chinelatti MA; Borsatto MC; Pécora JD; Palma-Dibb RG
Photomed Laser Surg; 2007 Feb; 25(1):26-33. PubMed ID: 17352634
[TBL] [Abstract][Full Text] [Related]
31. Fast and effective skin ablation with an Er:YAG laser: determination of ablation rates and thermal damage zones.
Hohenleutner U; Hohenleutner S; Bäumler W; Landthaler M
Lasers Surg Med; 1997; 20(3):242-7. PubMed ID: 9138252
[TBL] [Abstract][Full Text] [Related]
32. Combined UV and IR laser ablation of dentine.
Sciberras HC; Dair GT; Vansaarloos PP; Boyd N
J Clin Laser Med Surg; 2001 Feb; 19(1):21-7. PubMed ID: 11547814
[TBL] [Abstract][Full Text] [Related]
33. Initial clinical experience with an erbium:YAG laser for vitreoretinal surgery.
D'Amico DJ; Brazitikos PD; Marcellino GR; Finn SM; Hobart JL
Am J Ophthalmol; 1996 Apr; 121(4):414-25. PubMed ID: 8604735
[TBL] [Abstract][Full Text] [Related]
34. Optimization of the Erbium:YAG laser for precise incision of ureteral and urethral tissues: in vitro and in vivo results.
Fried NM; Tesfaye Z; Ong AM; Rha KH; Hejazi P
Lasers Surg Med; 2003; 33(2):108-14. PubMed ID: 12913882
[TBL] [Abstract][Full Text] [Related]
35. YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.
Shah CP; Heier JS
JAMA Ophthalmol; 2017 Sep; 135(9):918-923. PubMed ID: 28727887
[TBL] [Abstract][Full Text] [Related]
36. Optical fibers for endoscopic high-power Er:YAG laserosteotomy.
Beltrán Bernal LM; Canbaz F; Darwiche SE; Nuss KMR; Friederich NF; Cattin PC; Zam A
J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34519191
[TBL] [Abstract][Full Text] [Related]
37. Er:YAG laser ablation of enamel and dentin of human teeth: determination of ablation rates at various fluences and pulse repetition rates.
Li ZZ; Code JE; Van De Merwe WP
Lasers Surg Med; 1992; 12(6):625-30. PubMed ID: 1453865
[TBL] [Abstract][Full Text] [Related]
38. A reconstituted in vitro clot model for evaluating laser thrombolysis.
Janis AD; Buckley LA; Nyara AN; Prahl SA; Gregory K
J Thromb Thrombolysis; 2002 Jun; 13(3):167-75. PubMed ID: 12355034
[TBL] [Abstract][Full Text] [Related]
39. Laser vitreolysis for symptomatic floaters is not yet ready for widespread adoption.
Su D; Shah CP; Hsu J
Surv Ophthalmol; 2020; 65(5):589-591. PubMed ID: 32135173
[TBL] [Abstract][Full Text] [Related]
40. A promising approach in laser vitrectomy executed by plasma-mediated removal of vitreous body via a diode-pumped Q-switched Nd:YAG laser.
Uthoff D; Oravecz R; Kuehnl R; Rubin-Schwarz F; Frentzen M; Schrage N; Meister J
Sci Rep; 2020 Dec; 10(1):21710. PubMed ID: 33303956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
